Korangy F - Search Results

1

Biomarkers for immunotherapy of hepatocellular carcinoma.

Greten TF, Villanueva A, Korangy F, Ruf B, Yarchoan M, Ma L, Ruppin E, Wang XW. Greten TF, et al. Among authors: korangy f. Nat Rev Clin Oncol. 2023 Nov;20(11):780-798. doi: 10.1038/s41571-023-00816-4. Epub 2023 Sep 19. Nat Rev Clin Oncol. 2023. PMID: 37726418 Review.

2

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. Among authors: korangy f. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

3

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

4

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Ormandy LA, et al. Among authors: korangy f. Cancer Res. 2005 Mar 15;65(6):2457-64. doi: 10.1158/0008-5472.CAN-04-3232. Cancer Res. 2005. PMID: 15781662

5

Immunotherapy of hepatocellular carcinoma.

Greten TF, Manns MP, Korangy F. Greten TF, et al. Among authors: korangy f. J Hepatol. 2006 Dec;45(6):868-78. doi: 10.1016/j.jhep.2006.09.004. Epub 2006 Sep 29. J Hepatol. 2006. PMID: 17046096 Review. No abstract available.

6

Immune based therapies in cancer.

Krüger C, Greten TF, Korangy F. Krüger C, et al. Among authors: korangy f. Histol Histopathol. 2007 Jun;22(6):687-96. doi: 10.14670/HH-22.687. Histol Histopathol. 2007. PMID: 17357098 Review.

7

Immunotherapy of HCC.

Greten TF, Manns MP, Korangy F. Greten TF, et al. Among authors: korangy f. Rev Recent Clin Trials. 2008 Jan;3(1):31-9. doi: 10.2174/157488708783330549. Rev Recent Clin Trials. 2008. PMID: 18474013 Review.

8

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, Manns MP, Greten TF, Korangy F. Hoechst B, et al. Among authors: korangy f. Gastroenterology. 2008 Jul;135(1):234-43. doi: 10.1053/j.gastro.2008.03.020. Epub 2008 Mar 21. Gastroenterology. 2008. PMID: 18485901

9

Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells.

Lankiewicz S, Rother E, Zimmermann S, Hollmann C, Korangy F, Greten TF. Lankiewicz S, et al. Among authors: korangy f. Cell Oncol. 2008;30(6):463-71. doi: 10.3233/clo-2008-0432. Cell Oncol. 2008. PMID: 18936523 Free PMC article.

10

Molecular therapy for the treatment of hepatocellular carcinoma.

Greten TF, Korangy F, Manns MP, Malek NP. Greten TF, et al. Among authors: korangy f. Br J Cancer. 2009 Jan 13;100(1):19-23. doi: 10.1038/sj.bjc.6604784. Epub 2008 Nov 18. Br J Cancer. 2009. PMID: 19018262 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page